FDA advisers vote to ease peptide restrictions, despite agency concerns : NPR
• FDA advisers voted to ease restrictions on popular peptides, potentially allowing specialized pharmacies to produce these compounds within the United States. • The decision comes despite agency concerns that these peptides lack the large, well-controlled human clinical trials required to establish safety and effectiveness for formal drug approval. • This move matters as it could increase the domestic availability of peptides, though it bypasses the rigorous evidence standards typically mandated for new medications.
npr.org










